Current Trends in Glioblastoma Multiforme Treatment: Radiation Therapy and Immune Checkpoint Inhibitors

Glioblastoma multiforme (GBM) is the most common primary brain cancer. Even with aggressive combination therapy, the median life expectancy for patients with GBM remains approximately 14 months. In order to improve the outcomes of patients with GBM, the development of newer treatments is critical. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicholas, Sarah, Mathios, Dimitris, Ruzevick, Jacob, Jackson, Christopher, Yang, Isaac, Lim, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Brain Tumor Society and The Korean Society for Neuro-Oncology 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027120/
https://www.ncbi.nlm.nih.gov/pubmed/24904882
http://dx.doi.org/10.14791/btrt.2013.1.1.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027120/
https://www.ncbi.nlm.nih.gov/pubmed/24904882
http://dx.doi.org/10.14791/btrt.2013.1.1.2

Ejemplares similares